ISRG vs LXRX · P/E 80, rev $2.89B vs rev $21.8M
Intuitive Surgical Inc (ISRG) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
Intuitive Surgical Inc (ISRG) is a medical instruments & supplies company listed on US.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported ISRG revenue for 2026-06-30 was $2.89B. Net income was $818.1M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. ISRG currently screens at market cap $195.15B and trailing P/E 80.0.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
ISRG currently screens at market cap $195.15B and trailing P/E 80.0. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the ISRG and LXRX stock pages for the full models.
Not investment advice.